MARKET

KRON

KRON

Kronos Bio, Inc.
NASDAQ
0.8951
-0.0372
-3.99%
Closed 16:00 03/19 EDT
OPEN
0.9220
PREV CLOSE
0.9323
HIGH
0.9485
LOW
0.8716
VOLUME
220.27K
TURNOVER
--
52 WEEK HIGH
1.600
52 WEEK LOW
0.6900
MARKET CAP
54.01M
P/E (TTM)
-0.6210
1D
5D
1M
3M
1Y
5Y
1D
Kronos Bio  GAAP EPS of -$0.43, revenue of $2.27M
Seeking Alpha · 1d ago
Kronos Bio Inc Q4 Sales Decline
NASDAQ · 1d ago
Kronos Bio Q4 2024 GAAP EPS $(0.43) Misses $(0.38) Estimate, Sales $2.270M Miss $2.420M Estimate
Benzinga · 1d ago
*Kronos Bio 4Q Rev $2.27M >KRON
Dow Jones · 1d ago
BRIEF-Kronos Bio Q4 EPS USD -0.43
Reuters · 1d ago
KRONOS BIO REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
Reuters · 1d ago
Press Release: Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results
Dow Jones · 1d ago
*Kronos Bio 4Q Loss/Shr 43c >KRON
Dow Jones · 1d ago
More
About KRON
Kronos Bio, Inc. is a biopharmaceutical company. The Company is focused on developing therapeutics that target the deregulated transcription that causes cancer and other serious diseases. It is developing KB-0742, its internally discovered oral cyclin dependent kinase 9 (CDK9) inhibitor, for the treatment of MYC-amplified and others transcriptionally addicted solid tumors. It has initiated the Phase 2 portion of its Phase 1/2 clinical trial for KB-0742. It is also developing KB-9558, which inhibits the lysine acetyltransferase (KAT) domain of p300, a critical node of the IRF4 TRN. IRF4 is a key transcription factor driver in multiple myeloma and KB-9558 selectively targets its activity. Its scientific focus is on developing medicines that target deregulated transcription, the hallmark of cancer and other serious diseases. Using its Small Molecule Microarray (SMM) platform or other approaches, it can generate and advance small molecule starting points into drug development candidates.

Webull offers Kronos Bio Inc stock information, including NASDAQ: KRON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KRON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KRON stock methods without spending real money on the virtual paper trading platform.